Last reviewed · How we verify

NCT04666246: PERSIA

Inspiratory Effort in COVID-19

Recruiting now Last updated 25 April 2025
What this trial tests

trial in Acute Respiratory Failure in 40 participants. Currently enrolling.

Timeline
1 March 2020
Primary endpoint
1 June 2024
1 February 2030

Quick facts

Lead sponsorUniversity of Modena and Reggio Emilia
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment40
Start date1 March 2020
Primary completion1 June 2024
Estimated completion1 February 2030
Sites1 location across Italy

Conditions studied

Sponsor

University of Modena and Reggio Emilia

Who can join

Adults 18 to 80, any sex, with Acute Respiratory Failure or Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims at assessing esophageal pressure in patients with acute respiratory failure due to COVID-19 undergoing non invasive respiratory support.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Acute Respiratory Failure

Currently open trials in the same condition.

Other University of Modena and Reggio Emilia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04666246.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing